These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 31564830

  • 1. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
    Yuan M, Meng XW, Ma J, Liu H, Song SY, Chen QC, Liu HY, Zhang J, Song N, Ji FH, Peng K.
    Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
    [Abstract] [Full Text] [Related]

  • 2. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y, Zhao Q, Li X, Ji F.
    Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
    [Abstract] [Full Text] [Related]

  • 3. HSP70 protects H9C2 cells from hypoxia and reoxygenation injury through STIM1/IP3R.
    Liu T, Juan Z, Xia B, Ren G, Xi Z, Hao J, Sun Z.
    Cell Stress Chaperones; 2022 Sep; 27(5):535-544. PubMed ID: 35841499
    [Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
    Zhu Z, Ling X, Zhou H, Zhang C, Yan W.
    Drug Des Devel Ther; 2020 Sep; 14():4231-4243. PubMed ID: 33116411
    [Abstract] [Full Text] [Related]

  • 5. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH, Jin MM, Liu JT.
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway.
    Feng P, Zhang A, Su M, Cai H, Wang X, Zhang Y.
    Brain Res; 2021 Jan 01; 1750():147141. PubMed ID: 33017590
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
    Shi X, Liu Z, Li J.
    Mol Med Rep; 2020 Oct 01; 22(4):3307-3315. PubMed ID: 32945482
    [Abstract] [Full Text] [Related]

  • 8. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
    Wang J, Tang Z, Zhang Y, Qiu C, Zhu L, Zhao N, Liu Z.
    Eur J Pharmacol; 2019 Jan 05; 842():118-124. PubMed ID: 30339815
    [Abstract] [Full Text] [Related]

  • 9. Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy.
    Shao Q, Xia J, Wu P, Ying J.
    Microcirculation; 2021 May 05; 28(4):e12675. PubMed ID: 33377581
    [Abstract] [Full Text] [Related]

  • 10. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-κB Signaling.
    Gao JM, Meng XW, Zhang J, Chen WR, Xia F, Peng K, Ji FH.
    Biomed Res Int; 2017 May 05; 2017():1674613. PubMed ID: 29359143
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
    Zhao Y, Kong GY, Pei WM, Zhou B, Zhang QQ, Pan BB.
    Eur Cytokine Netw; 2019 Sep 01; 30(3):88-97. PubMed ID: 31957703
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of Stim1 reduced intracellular calcium concentration and attenuated hypoxia/reoxygenation induced apoptosis in H9C2 cells.
    He F, Wu Q, Xu B, Wang X, Wu J, Huang L, Cheng J.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29089467
    [Abstract] [Full Text] [Related]

  • 16. Interference with GPR4 inactivates NLRP3 inflammasome signaling by inhibiting LPAR1 expression to ameliorate oxygen-glucose deprivation/reoxygenation-induced inflammation and apoptosis of cardiomyocytes.
    He H, Su H, Chen X, Chen X, Yang S.
    Prostaglandins Other Lipid Mediat; 2024 Oct 22; 174():106863. PubMed ID: 38936540
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.